BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in The Clorox Company (NYSE:CLX) by 12.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 23,245 shares of the company’s stock after purchasing an additional 2,598 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in The Clorox were worth $4,182,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Stonebridge Capital Advisors LLC bought a new position in shares of The Clorox in the first quarter worth approximately $27,000. Bogart Wealth LLC lifted its stake in The Clorox by 73.1% in the second quarter. Bogart Wealth LLC now owns 180 shares of the company’s stock worth $32,000 after acquiring an additional 76 shares during the period. Sage Financial Management Group Inc. purchased a new stake in The Clorox in the first quarter worth $39,000. Harbour Investments Inc. purchased a new stake in The Clorox in the first quarter worth $40,000. Finally, E Fund Management Co. Ltd. purchased a new stake in The Clorox in the first quarter worth $43,000. Hedge funds and other institutional investors own 77.77% of the company’s stock.
CLX has been the subject of a number of research analyst reports. Morgan Stanley dropped their price target on The Clorox from $170.00 to $160.00 and set an “underweight” rating for the company in a research note on Wednesday, August 4th. UBS Group dropped their price target on The Clorox from $166.00 to $154.00 and set a “sell” rating for the company in a research note on Wednesday, August 4th. They noted that the move was a valuation call. Atlantic Securities lowered The Clorox from an “overweight” rating to a “neutral” rating and set a $150.00 price target for the company. in a research note on Wednesday, August 4th. Credit Suisse Group lowered their price objective on The Clorox from $175.00 to $160.00 and set a “neutral” rating for the company in a research report on Wednesday, August 4th. Finally, Zacks Investment Research lowered The Clorox from a “hold” rating to a “strong sell” rating and set a $139.00 price objective for the company. in a research report on Friday, August 6th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $182.44.
The Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, August 3rd. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.29 by ($0.34). The company had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.91 billion. The Clorox had a return on equity of 94.42% and a net margin of 9.67%. The Clorox’s revenue for the quarter was down 9.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.41 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 5.54 EPS for the current year.
The Clorox Profile
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.
See Also: Why do earnings reports matter?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).
Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.